Intermittent Preventive Treatment (IPTi) for the Prevention of Malaria and Anaemia in PNG Infants

NACompletedINTERVENTIONAL
Enrollment

1,100

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
MalariaAnemia
Interventions
DRUG

Amodiaquine/sulphadoxine-pyrimethamine, Artesunate/sulphadoxine-pyrimethamine or placebo

Children will get 25mg/1.25mg/kg of SP as a single dose, 4 mg/kg for 3 days of Artesunate and 10 mg/kg for 3 days of Amodiaquine in their respective arms

Trial Locations (1)

Unknown

Papua New Guinea Institute of Medical Research, Goroka

All Listed Sponsors
collaborator

University of Melbourne

OTHER

collaborator

Case Western Reserve University

OTHER

lead

Papua New Guinea Institute of Medical Research

OTHER_GOV

NCT00285662 - Intermittent Preventive Treatment (IPTi) for the Prevention of Malaria and Anaemia in PNG Infants | Biotech Hunter | Biotech Hunter